0HG8.L - Elevance Health, Inc.

Top Stock Reports for Meta Platforms, Boeing & IBM

Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (META), The Boeing Company (BA) and International Business Machines Corporation (IBM).

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

• 
  Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

  Zacks
• 
  Why Allegion (ALLE) is a Top Growth Stock for the Long-Term

  Zacks

Top Research Reports for Tesla, TotalEnergies & Intuitive Surgical

Today's Research Daily features new research reports on 16 major stocks, including Tesla, Inc. (TSLA), TotalEnergies SE (TTE) and Intuitive Surgical, Inc. (ISRG).

Why Elevance Health (ELV) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

• 
  Why Lear (LEA) is a Top Value Stock for the Long-Term

  Zacks
• 
  Why AutoZone (AZO) is a Top Value Stock for the Long-Term

  Zacks

Here's Why You Should Hold Elevance (ELV) in Your Portfolio

Improving top line, investments in high-growth businesses, membership hikes and significant new contracts in its government business poise Elevance Health (ELV) well for growth.

• 
  Here's Why Hold Strategy is Apt for Sun Life (SLF) Stock

  Zacks
• 
  5 Reasons Why Trustmark Corporation (TRMK) Stock Is a Must Buy

  Zacks

Why Is Elevance Health (ELV) Up 0% Since Last Earnings Report?

Elevance Health (ELV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

2 Top Healthcare Stocks to Buy Right Now

Higher interest rates and plunging growth forecasts have been the economic fallout from inflation that has been elevated throughout some of 2021, all of 2022, and all this year so far. Given the essential nature of the goods and services provided by the healthcare sector, it is arguably one of the more durable economic sectors. Pfizer (NYSE: PFE) is probably best known today for its COVID-19 vaccine, Comirnaty, which it co-owns with BioNTech, and the COVID-19 antiviral treatment Paxlovid.

Cigna (CI) Q1 Earnings Surpass Estimates, Ups '23 EPS View

Cigna's (CI) first-quarter 2023 results indicate a strong contribution to revenues from Evernorth Health Services and Cigna Healthcare businesses. Management currently expects adjusted EPS to be a minimum of $24.70 in 2023.

Acadia Healthcare (ACHC) Q1 Earnings Beat on Higher Patient Volumes

Acadia Healthcare's (ACHC) Q1 results reflect higher revenue per patient day, partly offset by an elevated cost level. Management reaffirms its 2023 business guidance.

Teladoc Health (TDOC) Shares Up 5% Since Q1 Earnings Release

Teladoc Health's (TDOC) Q1 results reflect solid chronic care product revenues and improving access fees and other revenues.

ELV vs. AMEH: Which Stock Is the Better Value Option?

ELV vs. AMEH: Which Stock Is the Better Value Option?

AMN Healthcare (AMN) to Post Q1 Earnings: What's in the Cards?

AMN Healthcare's (AMN) first-quarter results are likely to reflect soft demand across its segments.

Universal Health (UHS) Q1 Earnings Beat on Higher Admissions

Universal Health's (UHS) Q1 results reflect strong performance in acute care and behavioral health segments. Meanwhile, the elevated expense level partially offsets the positives.

Humana (HUM) Q1 Earnings Beat on Growing Membership & Premiums

Humana (HUM) expects adjusted EPS to be at least $28.25 in 2023, up from the previous guidance of $28 per share.

Centene (CNC) Q1 Earnings Miss Estimates, '23 EPS View Raised

Centene's (CNC) first-quarter 2023 results grapple with higher operating expenses, partly offset by an expanding customer base. Management presently expects adjusted EPS to be at least $6.40 in 2023.

Should Dividend Growth Investors Buy This Blue Chip Healthcare Stock?

While the stock market tends to appropriately value stocks over the long run, this is far from always the case in the short term. The element of human emotion can often send stocks soaring or plunging beyond anything that their fundamentals would justify.

Elevance Health (ELV) is an Incredible Growth Stock: 3 Reasons Why

Elevance Health (ELV) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Elevance Health's (NYSE:ELV) Upcoming Dividend Will Be Larger Than Last Year's

Elevance Health, Inc. ( NYSE:ELV ) has announced that it will be increasing its dividend from last year's comparable...

HCA Healthcare (HCA) Beats on Q1 Earnings, Ups '23 EPS View

HCA Healthcare's (HCA) first-quarter results gain from increased patient admissions. Management expects EPS within the $17.25-$18.55 band this year, higher than the previous view of $16.40-$17.60.

Elevance Health (ELV) Beats on Q1 Earnings, Hikes Profit View

Elevance Health's (ELV) first-quarter results reflect growing premiums stemming from rate increases.

Elevance Health (ELV) Reports Q1 Earnings: What Key Metrics Have to Say

The headline numbers for Elevance Health (ELV) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Elevance Health (ELV) Tops Q1 Earnings and Revenue Estimates

Elevance Health (ELV) delivered earnings and revenue surprises of 2.16% and 2.48%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ELV or DOCS: Which Is the Better Value Stock Right Now?

ELV vs. DOCS: Which Stock Is the Better Value Option?

Elevance Health (ELV) to Post Q1 Earnings: What's in Store?

Elevance Health's (ELV) first-quarter results are likely to reflect higher premiums, commercial and government sales figures and total expenses.